Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 35
- Next page
Title Sort descending | Authors | Year | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Risk of exposure to Zika virus and impact on cord blood banking and adult unrelated donors in hematopoietic cell transplantation: the Canadian Blood Services experience | Adams Z, Morris G, Campbell T, Mostert K, Dibdin N, Fearon M, Elmoazzen H, Mercer D, Young K, Allan D | 2018 | Biol Blood Marrow Transplant | View Risk of exposure to Zika virus and impact on cord blood banking and adult unrelated donors in hematopoietic cell transplantation: the Canadian Blood Services experience | Blood operators | Clinical research |
Risk of serious gastrointestinal bleeding in living kidney donors | Thomas SM, Lam NN, Huang A, Nash DM, Prasad GV, Knoll GA, Koval JJ, Lentine KL, Kim SJ, Alam A, Lok CE, Treleaven DJ, Garg AX | 2014 | Clin Transplant | View Risk of serious gastrointestinal bleeding in living kidney donors | Health care providers | Clinical research |
Risk of transfusion-transmitted Babesia microti in Canada | O'Brien SF, Drews SJ, Yi Q-L, Bloch EM, Ogden NH, Koffi JK, Lindsay LR, Gregoire Y, Delage G | 2021 | Transfusion | View Risk of transfusion-transmitted Babesia microti in Canada | Researchers | Benchmarking and standard setting |
Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature review | Leblanc J-F, Germain M, Delage G, O'Brien S, Drews SJ, Lewin A | 2020 | Transfusion | View Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature review | Health care providers | Clinical research |
Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews | Darzi AJ, Repp AB, Spencer FA, Morsi RZ, Charide R, Etxeandia-Ikobaltzeta I, Bauer KA, Burnett AE, Cushman M, Dentali F, Kahn SR, Rezende SM, Zakai NA, Agarwal A, Karam SG, Lotfi T, Wiercioch W, Waziry R, Iorio A, Akl EA, Schünemann HJ | 2020 | Blood Adv | View Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews | Health care providers | Clinical research |
Risk-based decision making in transfusion medicine | Leach Bennett J, Devine DV | 2018 | Vox Sang | View Risk-based decision making in transfusion medicine | Researchers | New or improved product or process |
Risk-based decision-making for blood safety: preliminary report of a consensus conference | Stein J, Besley J, Brook C, Hamill M, Klein E, Krewski D, Murphy G, Richardson M, Sirna J, Skinner M, Steiner R, van Aken P, Devine D | 2011 | Vox Sang | View Risk-based decision-making for blood safety: preliminary report of a consensus conference | Blood operators | Other |
Risks and trends of red blood cell transfusion in obstetric patients: a retrospective study of 45,213 deliveries using administrative data | Shehata N, Chassé M, Colas JA, Murphy M, Forster AJ, Malinowski AK, Ducharme R, Fergusson DA, Tinmouth A, Wilson K | 2017 | Transfusion | View Risks and trends of red blood cell transfusion in obstetric patients: a retrospective study of 45,213 deliveries using administrative data | Health care providers | Clinical research |
Risks, benefits and the role of stakeholders in pathogen reduction technology | Newbold KB, Heddle NM, Lane SJ, Arnold E, Eyles J, Webert K | 2014 | Health Risk Soc | View Risks, benefits and the role of stakeholders in pathogen reduction technology | Other | Other |
Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura | Bhagirath VC, Kelton JG, Moore J, Arnold DM | 2012 | Transfusion | View Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura | Health care providers | Clinical research |
Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis | Chugh S, Darvish-Kazem S, Lim W, Crowther MA, Ghanima W, Wang G, Heddle NM, Kelton JG, Arnold DM | 2015 | Lancet Haematol | View Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis | Health care providers | Clinical research |
Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Carter RLR, Talbot K, Hur WS, Meixner SC, Van Der Gugten JG, Holmes DT, Côté HCF, Kastrup CJ, Smith TW, Lee AYY, Pryzdial ELG | 2018 | J Thromb Haemost | View Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Health care providers | Basic research |
Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography | Gantioqui J, Stevic I, Atkinson H, Chan AKC | 2018 | Blood Coagul Fibrinolysis | View Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography | Researchers | Basic research |
Role of G protein-coupled vasoactive intestinal peptide receptors in HIV integration | Branch DR | 2011 | Future Virol | View Role of G protein-coupled vasoactive intestinal peptide receptors in HIV integration | Researchers | Basic research |
Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage | Wan H, Wang Y, Ai J, Brathwaite S, Ni H, Macdonald RL, Hol EM, Meijers JCM, Vergouwen MDI | 2018 | J Thromb Haemost | View Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage | Researchers | Basic research |
Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients | Chelle P, Yeung CHT, Bonanad S, Morales Munoz JC, Ozelo MC, Megias Vericat JE, Iorio A, Spears J, Mir R, Edginton A | 2019 | J Pharmacokinet Pharmacodyn | View Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients | Health care providers | Clinical research |
Routine nucleic acid testing of blood donations fails to detect all human immunodeficiency virus–positive blood donors | Fearon M, Scalia V, Lane D, Bigham M, Hawes G, O'Brien S, Kadkhoda K | 2016 | Transfusion | View Routine nucleic acid testing of blood donations fails to detect all human immunodeficiency virus–positive blood donors | Health care providers | Clinical research |
Routine screening method for microparticles in platelet transfusions | Millar D, Murphy L, Labrie A, Maurer-Spurej E | 2018 | J Vis Exp | View Routine screening method for microparticles in platelet transfusions | Health care providers | New or improved product or process |
Safeguarding the Patient's Own Blood Supply | Zeller MP, Kaufman RM | 2019 | JAMA | View Safeguarding the Patient's Own Blood Supply | Health care providers | Clinical research |
Safety and efficacy of self-administered romiplostim in patients with immune thrombocytopenia: Results of an integrated database of five clinical trials | Kuter DJ, Arnold DM, Rodeghiero F, Janssens A, Selleslag D, Bird R, Newland A, Mayer J, Wang K, Olie R | 2020 | Am J Hematol | View Safety and efficacy of self-administered romiplostim in patients with immune thrombocytopenia: Results of an integrated database of five clinical trials | Researchers | Clinical research |
Safety of blood donation by individuals over age 70 and their contribution to the blood supply in five developed countries: a BEST Collaborative group study | Goldman M, Germain M, Gregoire Y, Vassallo RR, Kamel H, Bravo M, Irving DO, Di Angelantonio E, Steele WR, O'Brien SF, for the Biomedical Excellence for Safer Transfusion Collaborative (BEST) Investigators | 2019 | Transfusion | View Safety of blood donation by individuals over age 70 and their contribution to the blood supply in five developed countries: a BEST Collaborative group study | Blood operators | New or improved product or process |
Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials | Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, Granton J, Stewart DJ, Canadian Critical Care Trials Group | 2012 | PLoS One | View Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials | Researchers | Clinical research |
Sample collection and sample handling errors submitted to the transfusion error surveillance system, 2006 to 2015 | Strauss R, Downie H, Wilson A, Mounchili A, Berry B, Cserti-Gazdewich C, Callum J | 2018 | Transfusion | View Sample collection and sample handling errors submitted to the transfusion error surveillance system, 2006 to 2015 | Health care providers | Clinical research |
SARS in Canada: Lessons learned for the blood operator | Devine DV | 2020 | Transfus Med | View SARS in Canada: Lessons learned for the blood operator | Blood operators | Other |
SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada | Saeed S, Drews SJ, Pambrun C, Yi Q-L, Osmond L, O'Brien SF | 2021 | Transfusion | View SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada | Researchers | Clinical research |
SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron | O’Brien SF, Caffrey N, Yi Q-L, Pambrun C, Drews SJ | 2022 | Viruses | View SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron | Researchers | Clinical research |
SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada | Goldfarb DM, Mâsse LC, Watts AW, Hutchison SM, Muttucomaroe L, Bosman ES, Barakauskas VE, Choi A, Irvine MA, Reicherz F, Coombs D, O’Reilly C, Sediqi S, Razzaghian HR, Sadarangani M, O’Brien SF, Lavoie PM | 2021 | medRxiv | View SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada | Researchers | Clinical research |
SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study | Goldfarb DM, Mâsse LC, Watts AW, Hutchison SM, Muttucomaroe L, Bosman ES, Barakauskas VE, Choi A, Dhillon N, Irvine MA, Reicherz F, O’Reilly C, Sediqi S, Xu RY, Razzaghian HR, Sadarangani M, Coombs D, O’Brien SF, Lavoie PM | 2022 | BMJ Open | View SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study | Researchers | Clinical research |
SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia | Appelbaum J, Arnold DM, Kelton JG, Gernsheimer T, Jevtic SD, Ivetic N, Smith JW, Nazy I | 2022 | Blood Adv | View SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia | Researchers | Basic research |
SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History | Drews SJ, Hu Q, Samson R, Abe KT, Rathod B, Colwill K, Gingras A-C, Yi Q-L, O’Brien SF, Mostafa HH | 2022 | Microbiol Spectr | View SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History | Researchers | Clinical research |
Scanning the future of transfusion medicine | Devine D, Dzik WH, Szczepiorkowski ZM | 2013 | Practical Transfusion Medicine, 4th edition | View Scanning the future of transfusion medicine | Health care providers | Other |
SCAR: The high-prevalence antigen 013.008 in the Scianna blood group system | Srivastava K, Albasri J, Alsuhaibani OM, Aljasem HA, Bueno MU, Antonacci T, Branch DR, Denomme GA, Flegel WA | 2021 | Transfusion | View SCAR: The high-prevalence antigen 013.008 in the Scianna blood group system | Researchers | Basic research |
Screening for high-risk sexual behavior in Canada | Goldman M, Caffrey N, O'Brien SF | 2022 | Transfusion | View Screening for high-risk sexual behavior in Canada | Blood operators | Clinical research |
Screening of Feijoa (Acca Sellowiana (O. Berg) Burret) Fruit Effect on Proliferation and Apoptosis using Bone Marrow derived Stem Cells Model | Rasekh H, Mahrabani D, Hosseini Farahi M, Masoumi S, Acker J | 2021 | Electron J Gen Med | View Screening of Feijoa (Acca Sellowiana (O. Berg) Burret) Fruit Effect on Proliferation and Apoptosis using Bone Marrow derived Stem Cells Model | Researchers | Basic research |
Screening of red blood cells for extracellular vesicle content as a product quality indicator | Acker JP, Almizraq RJ, Millar D, Maurer-Spurej E | 2018 | Transfusion | View Screening of red blood cells for extracellular vesicle content as a product quality indicator | Researchers | New or improved product or process |
Segments from red blood cell units should not be used for quality testing | Kurach JDR, Hansen AL, Turner TR, Jenkins C, Acker JP | 2014 | Transfusion | View Segments from red blood cell units should not be used for quality testing | Blood operators | New or improved product or process |
Selection and characterization of a DNA aptamer inhibiting coagulation factor XIa | Donkor DA, Bhakta V, Eltringham-Smith LJ, Stafford AR, Weitz JI, Sheffield WP | 2017 | Sci Rep | View Selection and characterization of a DNA aptamer inhibiting coagulation factor XIa | Researchers | Basic research |
Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin | Eltringham-Smith LJ, Bhakta V, Sheffield WP | 2021 | J Biotechnol | View Selection and in vitro and in vivo characterization of a Kunitz protease inhibitor domain of protease nexin 2 variant that inhibits factor XIa without inhibiting plasmin | Researchers | Basic research |
Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Goldman M, Drews S, Devine D | 2019 | Guide de la pratique transfusionnelle | View Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Health care providers | Benchmarking and standard setting |
Selective testing for Trypanosoma cruzi: the first year after implementation at Canadian Blood Services | O'Brien SF, Scalia V, Goldman M, Fan W, Yi QL, Dines IR, Huang M, Ndao M, Fearon MA | 2012 | Transfusion | View Selective testing for Trypanosoma cruzi: the first year after implementation at Canadian Blood Services | Blood operators | New or improved product or process |
Self-Assembly of a Functional Triple Protein: Hemoglobin-Avidin-Hemoglobin via Biotin–Avidin Interactions | Singh S, Kluger R | 2016 | Biochemistry | View Self-Assembly of a Functional Triple Protein: Hemoglobin-Avidin-Hemoglobin via Biotin–Avidin Interactions | Researchers | Basic research |
Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections | Grunau B, Tom J, Asamoah-Boaheng M, O’Brien SF, Drews SJ, Sediqi S, Lavoie PM, Barakauskas V, Goldfarb DM | 2022 | Open Forum Infect Dis | View Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections | Researchers | Basic research |
Septic transfusion case caused by a platelet pool with visible clotting due to contamination with Staphylococcus aureus | Loza-Correa M, Kou Y, Taha M, Kalab M, Ronholm J, Schlievert PM, Cahill MP, Skeate R, Cserti-Gazdewich C, Ramirez-Arcos S | 2017 | Transfusion | View Septic transfusion case caused by a platelet pool with visible clotting due to contamination with Staphylococcus aureus | Health care providers | Clinical research |
Serologic assessments in acute transfusion reactions: practices and yields | Cohen R, Lima A, Escorcia A, Tasmin F, Lin Y, Lieberman L, Pendergrast J, Callum J, Cserti-Gazdewich C | 2019 | Vox Sang | View Serologic assessments in acute transfusion reactions: practices and yields | Health care providers | Clinical research |
Serologic problems associated with administration of intravenous immune globulin (IVIg) | Branch DR | 2019 | Immunohematology | View Serologic problems associated with administration of intravenous immune globulin (IVIg) | Researchers | Clinical research |
Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: The BEST collaborative study | Lu W, Ziman A, Yan MTS, Waters A, Virk MS, Tran A, Tang H, Shih AW, Scally E, Raval JS, Pandey S, Pagano MB, Shan H, Moore C, Morrison D, Cormack O, Fitzgerald J, Duncan J, Corean J, Clarke G, Yazer M | 2023 | Transfusion | View Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: The BEST collaborative study | Health care providers | Clinical research |
Serological best practices: Anti-M | Clarke G, Cote J, Lane D | 2017 | Blood.ca website | View Serological best practices: Anti-M | Health care providers | Benchmarking and standard setting |
Seroprevalence of Babesia microti infection in Canadian blood donors | O'Brien SF, Delage G, Scalia V, Lindsay R, Bernier F, Dubuc S, Germain M, Pilot G, Yi Q-L, Fearon MA | 2016 | Transfusion | View Seroprevalence of Babesia microti infection in Canadian blood donors | Blood operators | New or improved product or process |
Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT? | Warkentin TE, Smythe MA, Ali MA, Aslam N, Sheppard JI, Smith JW, Moore JC, Arnold DM, Nazy I | 2021 | Am J Hematol | View Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT? | Researchers | Clinical research |
Serpin Phage Display: The Use of a T7 System to Probe Reactive Center Loop Libraries with Different Serine Proteinases | de Souza LR, Scott BM, Bhakta V, Donkor DA, Perruzza DL, Sheffield WP | 2018 | Serpins: Methods and Protocols | View Serpin Phage Display: The Use of a T7 System to Probe Reactive Center Loop Libraries with Different Serine Proteinases | Researchers | Other |